Related Experiment Video
Updated: Feb 8, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Updated clinical overview on cardiac laminopathies: an electrical and mechanical disease
G Peretto1, S Sala1, S Benedetti2
1a Department of Cardiac Electrophysyology and Arrhythmology , IRCCS San Raffaele Hospital and University , Milan , Italy.
Insights
Cardiac laminopathies, caused by LMNA gene mutations, present diverse heart issues. This review synthesizes current knowledge to identify predictors for sudden death and heart failure in mutation carriers.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Cardiac laminopathies result from LMNA gene mutations, leading to varied electrical and mechanical heart abnormalities.
- Clinical presentations include dilated cardiomyopathy, bradyarrhythmias, and tachyarrhythmias, often in combined phenotypes.
Purpose of the Study:
- To review and synthesize current evidence on LMNA-associated heart disease.
- To identify clinical predictors for life-threatening complications like sudden cardiac death and end-stage heart failure.
- To establish a foundation for future studies aimed at risk stratification in mutation carriers.
Main Methods:
- Comprehensive literature review of recent evidence on cardiac laminopathies.
- Analysis of clinical manifestations and outcomes associated with LMNA gene mutations.
Main Results:
- LMNA gene mutations cause a spectrum of cardiac issues, including arrhythmias and cardiomyopathy.
- Identifying predictors for sudden cardiac death and heart failure is an ongoing challenge.
Conclusions:
- Cardiac laminopathies are complex genetic heart diseases requiring further research for effective risk prediction.
- Future studies should focus on identifying clinically useful predictors to stratify risk in both affected individuals and asymptomatic relatives.
Abstract:
Cardiac laminopathies, associated with mutations in the LMNA gene, encompass a wide spectrum of clinical manifestations, involving electrical and mechanical alterations of cardiomyocytes. Thus, dilated cardiomyopathy, bradyarrhythmias and atrial or ventricular tachyarrhythmias may occur in a number of combined phenotypes. Nowadays, some attempt has been made to identify clinical predictors for the most life-threatening complications of LMNA-associated heart disease, i.e. sudden cardiac death and end-stage heart failure. The goal of this manuscript is to combine the most recent evidences in an updated review to show the state-of-the-art of such a complex disease group. This is supposed to be the starting point to collect more data and design new ad hoc studies to identify clinically useful predictors to stratify risk in mutation carriers, including probands and their asymptomatic relatives.
Related Concept Videos
Clinical Trials: Overview
Mechanism of Cardiac Arrhythmias
Parkinson's Disease: Overview
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Cardiac Catheterization I: Pre-Procedure Overview

